Navigation Links
Exelixis Receives $150 Million Funding Commitment From Deerfield Management
Date:6/5/2008

ion draw at an exercise price equal to 20% above the average of the daily volume weighted average stock price for each of the 15 trading days following the day on which Exelixis notifies Deerfield that it is drawing the funds. All warrants can be settled in net shares at Deerfield's option.

"Our deal with Deerfield provides a high level of flexibility and uniquely addresses the challenges that pre-commercial biotech companies face in a challenging capital markets environment," said Frank Karbe, chief financial officer of Exelixis. "Most notably, it provides guaranteed access to capital and a high degree of control as to when and to what degree we draw and repay funds, thereby substantially increasing our ability to manage our cost of capital and minimize dilution."

Conference Call and Webcast

Exelixis management will discuss the Deerfield arrangement during a conference call beginning at 5:00 a.m. PT/8:00 a.m. ET Thursday, June 5. To listen to a webcast of the discussion, visit the Event Calendar page under Investors at http://www.exelixis.com. An archive of the webcast will be available until 7:00 a.m. PT/10:00 a.m. ET on July 5, 2008. Access numbers for this replay are 1-888-286-8010 (domestic) and 1-617-801-6888 (international); the replay passcode number is 33494166.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmit
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased ... with Switzerland -based Kenta Biotech ... monoclonal antibody (mAb) products, and technologies. This asset ... for treatment of infections by common pathogens including ... , Pseudomonas aeruginosa , Acinetobacter baumannii ...
(Date:5/17/2013)... May 17, 2013 Men’s skin is biologically ... La-roche Posay ) and has been known to react more ... men may be far from puberty, other acne causing factors ... causing breakouts, and threatening skin with unsightly acne scars. Adult ... Men’s Health on how to reduce and prevent ...
(Date:5/17/2013)... RURO Inc. is pleased to ... versatile refinement to the smart management solution. , ... advanced methodical management for transgenic animal colonies, genotyping ... network-based platform provides user access with a plethora ... to emphasize streamlined tasks, such as animal relocation ...
(Date:5/17/2013)... 2013 IAC Industries wants to share with ... laboratory needing to set up and furnish a research lab ... facility within a year’s time. How does a company make ... is temporary? What is efficient and cost-effective? , The ... IAC Industries. The planners at DisperSol determined that the concept ...
Breaking Biology Technology:Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2
... ST. PETERS, Mo., Sept. 11 MEMC Electronic,Materials, ... update related to Hurricane,Ike., The company reported ... Pasadena, Texas facility in preparation for Hurricane Ike. ... shutting down operations in,preparation for the heavy weather ...
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), today announced ... financial results on September,16, 2008., The Company will ... for the fiscal year-end call are as follows:, ... Time: 10:30 a.m. ET, 9:30 a.m. CT, 7:30 a.m. ...
... of food supply, as well as increasing concerns about environmental ... spiraling growth given the recent success of commercialized products and ... , ... San Jose, California (PRWEB) September ...
Cached Biology Technology:MEMC Provides Update on Hurricane Ike 2Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit 2Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts 2Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts 3Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts 4
(Date:5/15/2013)... benefit in moderating gout risk, new research reveals that ... uric acid (urate) levels to a clinically significant degree ... or in combination with allopurinol, appears to have a ... patients according to the results published in the American ... . , Gout is an inflammatory arthritis that ...
(Date:5/15/2013)... clinical trial to date to examine the efficacy of ... other than breast and ovarian cancer, the oral drug ... and prostate cancers. Results of the study, led by ... University of Pennsylvania and Sheba Medical Center in Tel ... of Clinical Oncology,s annual meeting in Chicago in early ...
(Date:5/15/2013)... from the middle Devonian era some 380 million ... of the capacity of ecosystems to remain stable in ... today (May 15) in the online journal PLOS ... the head counts of specimens paleontologists test the ... factors such as predation and organism body size from ...
Breaking Biology News(10 mins):Vitamin C does not lower uric acid levels in gout patients 2PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2Clam fossils divulge secrets of ecologic stability 2
... Tropical rain forests are treasure houses of biodiversity, but ... monitor their plant species over large areas. As a ... clearing, invasive plants, and other threats are affecting these ... is in the works, however. Gregory Asner of the ...
... pond,s edge eyeing a cricket on a blade of grass. ... insect with its tongue. This deceptively simple, remarkably fast feeding ... This fresh perspective could lead to designing more efficient electric ... like Parkinson,s. Science has long held that muscles behave ...
... A study from researchers at Children,s Hospital ... infection control intervention in elementary schools disinfecting ... helped reduce illness-related student absenteeism. ... millions of lost school days each year.(1) ...
Cached Biology News:Revolution in rain forest monitoring with MacArthur grant 2Toad research could leapfrog to new muscle model 2Study findings show infection control intervention helps keep kids in school 2
The FailSafe™ PROBES Real-Time PCR System enables rapid, precise optimization of PCR experiments in which the product is detected using fluorescent target-specific labeled probes....
Anti-hamster Ig HRP detection kit...
...
...
Biology Products: